Secondary analysis of PURE-01: Role of FDG-PET/CT in evaluating lymph node involvement of patients with muscle invasive bladder cancer (MIBC) receiving neoadjuvant pembrolizumab and radical cystectomy (RC).

Laura Marandino,Antonella Capozza,Alberto Briganti,Daniele Raggi,Elena Farè,Filippo Pederzoli,Andrea Gallina,Marco Bandini,Umberto Capitanio,Marco Bianchi,Giorgio Gandaglia,Nicola Fossati,Patrizia Giannatempo,Ettore Seregni,Andrea Salonia,Francesco Montorsi,Alessandra Alessi,Andrea Necchi

Secondary analysis of PURE-01: Role of FDG-PET/CT in evaluating lymph node involvement of patients with muscle invasive bladder cancer (MIBC) receiving neoadjuvant pembrolizumab and radical cystectomy (RC).

2020

Laura Marandino
Antonella Capozza
Alberto Briganti
Daniele Raggi
Elena Farè
Filippo Pederzoli
Andrea Gallina
Marco Bandini
Umberto Capitanio
Marco Bianchi
Giorgio Gandaglia
Nicola Fossati
Patrizia Giannatempo
Ettore Seregni
Andrea Salonia
Francesco Montorsi
Alessandra Alessi
Andrea Necchi

445Background: FDG-PET/CT has limited utility in clinical N0 (cN0) patients (pts) with MIBC who receive neoadjuvant chemotherapy and RC or RC alone (Dason, AUA19). Methods: In PURE-01 (NCT02736266)...

Keywords:

Lymph node
PET-CT
Pathology
Bladder cancer
Radiology
Cystectomy
Pembrolizumab
Medicine
secondary analysis
muscle invasive
fdg pet ct
Chemotherapy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations